Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Izotropic (1R3) Stock Price & Analysis

1 Followers

1R3 Stock Chart & Stats

€0.07€0.01(9.84%)
At close: 5:30 PM GMT+1
€0.11€0.12€0.13€0.14Jul 27Sep 23
Day’s Range
EUR 0.05 - EUR 0.07
52-Week Range
EUR 0.04 - EUR 0.24
Previous Close
EUR 0.06
Volume
N/A
Average Volume (3M)
0
Market Cap
EUR 5.50M
Enterprise Value
EUR 20.58M
Total Cash (Recent Filing)
EUR 57.78K
Total Debt (Recent Filing)
EUR 3.21M
Price to Earnings (P/E)
―
Beta
0.33
Next Earnings
Dec 22, 2026 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Focused Breast-Imaging Product

A clearly defined product focus gives Izotropic a specific clinical use case and a basis for commercialization in breast imaging. If the system gains adoption, its dedicated design could support a differentiated position within diagnostic workflows and provide a foundation for future sales and service revenue.

Improved Loss Trajectory

The substantial reduction in net losses from 2022–2023 indicates progress in controlling expenses or reducing development costs, even though profitability remains negative. Sustaining this improvement would extend financial runway and reduce the operating scale required to reach breakeven after commercialization.

Lower Historical Cash Burn

Cash consumption is materially below the levels reported in 2022 and 2023, showing that operating outflows have been reduced during the development phase. Continued discipline could preserve resources for product commercialization, although the company still needs to eliminate its underlying cash deficit.

Bears Say

No Commercial Revenue

The absence of revenue means Izotropic has not yet demonstrated commercial demand or a functioning sales engine for IzoView. This leaves future performance dependent on successful product commercialization, customer adoption, and conversion of development work into recurring system and support revenue.

Negative Equity And Rising Debt

Persistent negative equity and increasing debt weaken financial flexibility and raise the likelihood that additional capital will be needed to sustain operations. Future financing or recapitalization could impose unfavorable terms or dilute existing holders, while debt adds obligations before the business generates revenue.

Persistent Cash Dependence

Negative operating and free cash flow across every reported period shows that the current business does not fund itself. Until revenue begins covering expenses and development needs, Izotropic must depend on outside capital, limiting strategic flexibility and increasing exposure to financing risk.

Izotropic News

1R3 FAQ

What was Izotropic’s price range in the past 12 months?
Izotropic lowest stock price was €0.04 and its highest was €0.24 in the past 12 months.
What is Izotropic’s market cap?
Izotropic’s market cap is €5.50M.
When is Izotropic’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Izotropic’s earnings last quarter?
Izotropic released its earnings results on Aug 24, 2026. The company reported -€0.005 earnings per share for the quarter.
Is Izotropic overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Izotropic pay dividends?
Izotropic does not currently pay dividends.
What is Izotropic’s EPS estimate?
Izotropic’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Izotropic have?
Izotropic has 69,724,680 shares outstanding.
What happened to Izotropic’s price movement after its last earnings report?
Izotropic reported an EPS of -€0.005 in its last earnings report. Following the earnings report the stock price went down -2.679%.
Which hedge fund is a major shareholder of Izotropic?
Currently, no hedge funds are holding shares in DE:1R3
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology